This opportunity funds translational activities and small clinical studies aimed at advancing therapeutic and diagnostic devices for nervous and neuromuscular system disorders. Supported activities include clinical prototype implementation, safety and efficacy testing, design verification, obtaining IDE for significant risk studies, and conducting small clinical trials. The program is milestone-driven and involves NIH staff collaboration in project planning and progress monitoring.
Eligible applicants include a wide range of U.S.-based organizations such as private and public institutions of higher education, small businesses, nonprofits, government entities, tribal organizations, and others as specified. Eligibility is limited to U.S. entities.
